SKI Market

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Mankind Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543904

INE634S01028

396.9775917

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MANKIND

43.47

98304.73

EPS(TTM)

Face Value()

Div & Yield %

54.75

0.04

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	10421.18	9507.41	8629.25	8127.15	7486.22	5529.60
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	10421.18	9507.41	8629.25	8127.15	7486.22	5529.60
Other Income	326.10	554.65	374.03	162.78	203.81	148.08
Stock Adjustments	-35.37	13.68	48.20	-267.89	365.27	254.25
Total Income	10711.91	10075.74	9051.48	8022.04	8055.30	5931.93
EXPENDITURE :
Raw Materials	2589.80	2618.16	2618.31	2576.87	2886.71	2036.42
Power & Fuel Cost	97.78	89.14	80.91	62.00	60.36	47.16
Employee Cost	2367.04	2148.87	1921.09	1701.38	1462.76	1106.14
Other Manufacturing Expenses	234.66	211.70	145.78	113.62	93.57	56.71
Selling & Administrative Expenses	1905.45	1773.61	1518.78	1539.07	1378.52	966.82
Miscellaneous Expenses	211.11	254.27	125.69	168.47	131.08	192.07
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	7405.84	7095.75	6410.56	6161.40	6013.00	4405.31
Operating Profit	3306.07	2979.99	2640.92	1860.65	2042.30	1526.62
Interest	562.50	377.50	16.93	28.23	47.54	8.23
Gross Profit	2743.57	2602.49	2623.99	1832.42	1994.76	1518.39
Depreciation	428.57	394.76	335.26	269.58	123.33	78.19
Profit Before Tax	2315.00	2207.73	2288.73	1562.84	1871.43	1440.20
Tax	473.22	469.93	411.33	291.64	429.03	346.99
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-195.78	-48.19	1.24	22.94	52.98	8.84
Reported Net Profit	2037.56	1785.99	1876.16	1248.26	1389.42	1084.37
Extraordinary Items	-87.60	180.81	105.89	29.02	62.07	30.15
Adjusted Net Profit	2125.16	1605.18	1770.27	1219.24	1327.35	1054.22
Adjustment below Net Profit	38.21	-153.08	-6.66	-4.86	-0.79	-1.56
P & L Balance brought forward	11396.88	9763.97	7894.47	6624.90	5236.27	3747.13
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	41.27	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	13431.38	11396.88	9763.97	7868.30	6624.90	4829.95
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	100.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	1.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	49.36	43.29	46.83	31.16	34.68	27.07
Earnings Per Share(Adj)-Unit Curr	49.36	43.29	46.83	31.16	34.68	27.07
Book Value-Unit Curr	397.21	347.13	242.21	194.31	163.27	118.18
Book Value(Adj)-Unit Curr	397.21	347.13	242.21	194.31	163.27	118.18

76,152.86 -417.49
( -0.55%)

53,087.25 299.37
(0.57%)

7,688.45 35.98
(0.47%)

64,337.38 11.74
(0.02%)

10,831.87 75.42
(0.70%)

94.95 -0.29
(-0.30%)

110.11 -0.38
(-0.35%)

128.48 -0.52
(-0.40%)

0.59 0.00
(-0.47%)

EQUITY - MARKET SCREENER

Imp documents

76,152.86 -417.49 ( -0.55%)

53,087.25 299.37 (0.57%)

7,688.45 35.98 (0.47%)

64,337.38 11.74 (0.02%)

10,831.87 75.42 (0.70%)

94.95 -0.29 (-0.30%)

110.11 -0.38 (-0.35%)

128.48 -0.52 (-0.40%)

0.59 0.00 (-0.47%)

EQUITY - MARKET SCREENER

76,152.86 -417.49
( -0.55%)

53,087.25 299.37
(0.57%)

7,688.45 35.98
(0.47%)

64,337.38 11.74
(0.02%)

10,831.87 75.42
(0.70%)

94.95 -0.29
(-0.30%)

110.11 -0.38
(-0.35%)

128.48 -0.52
(-0.40%)

0.59 0.00
(-0.47%)